DR J CLAES O.R.L.
0860.403.163 · rovalta.com · 26/09/2026
DR J CLAES O.R.L.
Company — Normal situation.
Financial year 2023 · Closed on 23/03/2023
Overview
Identity
Source · BCE/KBODR J CLAES O.R.L. is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0860.403.163
- Legal form
- Private company with limited liability
- Contributed capital
- 74 400,00 €
- Latest accounts
- 23/03/2023
Financials
Source · NBB, 18 filingsTrend over 16 financial years
| 2023 | 2022 | 2021 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -3,8 k € | +24.5% | -5,1 k € | -103% | 150,5 k € | +17.5% | 128,2 k € | -7.5% | 138,5 k € |
| EBITDA | -4,5 k € | +13.3% | -5,2 k € | -104% | 127 k € | +16.5% | 109 k € | -8.4% | 119 k € |
| Operating result | -4,5 k € | +19.8% | -5,6 k € | -104% | 126,3 k € | +17.2% | 107,7 k € | -9.1% | 118,5 k € |
| Net result | -4,5 k € | -381% | -939 € | -101% | 89,2 k € | +25.1% | 71,3 k € | -1.7% | 72,5 k € |
| Balance sheet | |||||||||
| Equity | 699,1 k € | -0.6% | 703,6 k € | -0.1% | 704,5 k € | +55.0% | 454,6 k € | +18.6% | 383,3 k € |
| Total assets | 699,1 k € | -0.8% | 704,6 k € | -5.1% | 742,6 k € | +62.6% | 456,8 k € | +11.6% | 409,2 k € |
| Cash | 108,9 k € | -56.2% | 248,7 k € | -12.3% | 283,5 k € | +67.1% | 169,7 k € | +9.0% | 155,7 k € |
| Debts | 0 € | -100% | 1 k € | -96.9% | 33,1 k € | +1368% | 2,3 k € | -91.3% | 25,9 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20221 active · 6 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 23/03/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 3 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 04/05/2023 | 06/02/2023 | 08/07/2022 | 30/06/2021 | 08/07/2020 | 09/10/2019 |
| General meeting | 23/03/2023 | 03/02/2023 | 11/05/2022 | 12/05/2021 | 13/05/2020 | 08/05/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 18 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 23/03/2023 | 23/03/2023 | 04/05/2023 | Dutch | |
| Micro model | 31/12/2022 | 03/02/2023 | 06/02/2023 | Dutch | |
| Micro model | 31/12/2021 | 11/05/2022 | 08/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 12/05/2021 | 30/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 13/05/2020 | 08/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 08/05/2019 | 09/10/2019 | Dutch | |
| Micro model | 31/12/2017 | 09/05/2018 | 24/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 10/05/2017 | 01/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 11/05/2016 | 19/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 13/05/2015 | 02/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 14/05/2014 | 25/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 08/05/2013 | 25/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 09/05/2012 | 05/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 11/05/2011 | 08/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 12/05/2010 | 29/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 13/05/2009 | 30/07/2009 | Dutch | |
| Abridged model | 31/12/2007 | 14/05/2008 | 29/07/2008 | Dutch | |
| Abridged model | 31/12/2006 | 30/05/2007 | 26/06/2007 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20221 active · 6 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023-4,5 k €↓
- 2023Name changeDR. J. CLAES O.R.L. in vereffening
- 2022Annual accounts 2022-939 €↓
- 2021Annual accounts 202189,2 k €↑
- 2021Name changeDR. J. CLAES O.R.L.
- 2018Annual accounts 201871,3 k €↓
- 2017Annual accounts 201772,5 k €↑
- 2016Annual accounts 201661,7 k €↑
- 2015Annual accounts 201544,7 k €↓
- 2014Annual accounts 201456,5 k €↓
- 2013Annual accounts 201371,4 k €↑
- 2012Annual accounts 201268,7 k €↓
- 2011Annual accounts 201174,4 k €↓
- 2010Annual accounts 201075,6 k €↑
- 2009Annual accounts 200950,3 k €↓
- 2008Annual accounts 200852,6 k €↓
- 2007Annual accounts 200758,2 k €↑
- 2006Annual accounts 200635,9 k €